Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ion-paired moxifloxacin nanocrystal formulation improves treatment and prevention of ocular infection

Journal of Controlled Release(2025)10.1016/j.jconrel.2025.113634Source: DataRank Database

Ion-paired moxifloxacin nanocrystal formulation improves treatment and prevention of ocular infection is a research paper published in Journal of Controlled Release (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 2.77)OA: greenTopics (46)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Kiersten Malmberg,Ashwin Pasupathy,Aditya Josyula ORCID,Jairo Ortiz ORCID,Peter J. McDonnell ORCID

Live enrichment

PubMed:40096866 PMC:PMC11994289 OpenAlex:https://openalex.org/W4408477464

National Center for Advancing Translational Sciences

Grant: UL1TR001079

U.S. Department of Defense

Grant: W81XWH-20-1-0922

National Eye Institute

Grant: R01EY033386

National Eye Institute

Grant: T32EY007143

National Institutes of Health

Grant: P30EY001765

NCI NIH HHS

Grant: P30 CA006973

NIH HHS

Grant: S10 OD020091

NIH HHS

Grant: S10 OD016374

Research to Prevent Blindness

FWCI

2.77

Citation Percentile

0.9%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11994289/

publisherhttps://api.elsevier.com/content/article/PII:S0168365925002536?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0168365925002536?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jconrel.2025.113634

Fields of Study

Ocular Infections and TreatmentsOcular Diseases and Behçet’s SyndromeOcular Surface and Contact LensMedicineMaterials ScienceAnimalsMoxifloxacinRabbitsNanoparticlesAnti-Bacterial AgentsStaphylococcal InfectionsStaphylococcus aureusOphthalmic SolutionsDelayed-Action PreparationsMaleRatsRats, Sprague-DawleyFluoroquinolones

MeSH Terms

MoxifloxacinAnimalsAnti-Bacterial AgentsDelayed-Action PreparationsMaleOphthalmic SolutionsRabbitsStaphylococcal InfectionsStaphylococcus aureusRats, Sprague-DawleyFluoroquinolonesRatsNanoparticles

Keywords

MoxifloxacinNanocrystalMedicineIonOphthalmologyPharmacologyChemistryNanotechnologyMaterials scienceAntibioticsStaphylococcus aureusOcular InfectionVigamoxSubconjunctivalIntracameral Moxifloxacin

Sustainable Development Goals

SDG 0: Good health and well-being

Ion-paired moxifloxacin nanocrystal formulation improves treatment and prevention of ocular infection

FAIR Checklist

Authors (9)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)